Poly (ADP-ribose) polymerase (PARP) inhibition in cancer: Potential impact in cancer stem cells and therapeutic implications

被引：6
作者：
Rizvi, Asim [1 ,2 ]
Merlin, Marine A. [2 ,3 ]
Shah, Girish M. [2 ,3 ]
机构：
[1] Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh, India
[2] CHU Quebec Univ Laval Res Ctr, Neurosci Div, Quebec City, PQ G1V 4G2, Canada
[3] Univ Laval, Canc Res Ctr, Quebec City, PQ G1V 0A6, Canada
来源：
EUROPEAN JOURNAL OF PHARMACOLOGY | 2021年 / 911卷
关键词：
Cancer stem cells; Cancer therapy; PARP; PARP-Inhibitors (PARPi); Cell death; Differentiation; TUMOR-INITIATING CELLS; SYNTHETIC LETHALITY; DRUG-RESISTANCE; SELF-RENEWAL; DNA-DAMAGE; HETEROGENEITY; ACTIVATION; SOX2; DIVISION; PATHWAYS;
D O I：
10.1016/j.ejphar.2021.174546
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Inhibitors of poly(ADP-ribose) polymerase (PARP) are used in mono- or combination therapies for several malignancies. They are also used as maintenance therapy for some cancers after initial treatment. While the focus of this therapeutic approach is on the effect of PARP inhibition on the bulk tumour cells, in this review, we discuss their effect on the cancer stem cells. We identify key mediators and pathways in cancer stem cells whose response to PARP inhibition is not necessarily the same as the rest of the tumour cells. Since the cancer stem cells are known drivers of growth of tumours and their resistance to therapy, the clinical outcome might be drastically different than what is expected, if the effect of PARP inhibition on the cancer stem cells is not taken into account.
引用
收藏
页数：7
相关论文
共 93 条
[1]   Selective Inhibition of Parallel DNA Damage Response Pathways Optimizes Radiosensitization of Glioblastoma Stem-like Cells [J].
Ahmed, Shafiq U. ;
Carruthers, Ross ;
Gilmour, Lesley ;
Yildirim, Salih ;
Watts, Colin ;
Chalmers, Anthony J. .
CANCER RESEARCH, 2015, 75 (20) :4416-4428
[2]   Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins [J].
Alemasova, Elizaveta E. ;
Lavrik, Olga I. .
NUCLEIC ACIDS RESEARCH, 2019, 47 (08) :3811-3827
[3]   PARP Inhibition Induces Enrichment of DNA Repair-Proficient CD133 and CD117 Positive Ovarian Cancer Stem Cells [J].
Bellio, Chiara ;
DiGloria, Celeste ;
Foster, Rosemary ;
James, Kaitlyn ;
Konstantinopoulos, Panagiotis A. ;
Growdon, Whitfield B. ;
Rueda, Bo R. .
MOLECULAR CANCER RESEARCH, 2019, 17 (02) :431-445
[4]   Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases [J].
Berger, Nathan A. ;
Besson, Valerie C. ;
Boulares, A. Hamid ;
Burkle, Alexander ;
Chiarugi, Alberto ;
Clark, Robert S. ;
Curtin, Nicola J. ;
Cuzzocrea, Salvatore ;
Dawson, Ted M. ;
Dawson, Valina L. ;
Hasko, Gyorgy ;
Liaudet, Lucas ;
Moroni, Flavio ;
Pacher, Pal ;
Radermacher, Peter ;
Salzman, Andrew L. ;
Snyder, Solomon H. ;
Soriano, Francisco Garcia ;
Strosznajder, Robert P. ;
Sumegi, Balazs ;
Swanson, Raymond A. ;
Szabo, Csaba .
BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (02) :192-222
[5]   Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell [J].
Bonnet, D ;
Dick, JE .
NATURE MEDICINE, 1997, 3 (07) :730-737
[6]   PARP Inhibitors in Ovarian Cancer: The Route to "Ithaca" [J].
Boussios, Stergios ;
Karathanasi, Afroditi ;
Cooke, Deirdre ;
Neille, Cherie ;
Sadauskaite, Agne ;
Moschetta, Michele ;
Zakynthinakis-Kyriakou, Nikolaos ;
Pavlidis, Nicholas .
DIAGNOSTICS, 2019, 9 (02)
[7]   Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase [J].
Bryant, HE ;
Schultz, N ;
Thomas, HD ;
Parker, KM ;
Flower, D ;
Lopez, E ;
Kyle, S ;
Meuth, M ;
Curtin, NJ ;
Helleday, T .
NATURE, 2005, 434 (7035) :913-917
[8]   Asymmetric division: a marker for cancer stem cells? [J].
Bu, Pengcheng ;
Chen, Kai-Yuan ;
Lipkin, Steven M. ;
Shen, Xiling .
ONCOTARGET, 2013, 4 (07) :950-951
[9]   A microRNA miR-34a-Regulated Bimodal Switch Targets Notch in Colon Cancer Stem Cells [J].
Bu, Pengcheng ;
Chen, Kai-Yuan ;
Chen, Joyce Huan ;
Wang, Lihua ;
Walters, Jewell ;
Shin, Yong Jun ;
Goerger, Julian P. ;
Sun, Jian ;
Witherspoon, Mavee ;
Rakhilin, Nikolai ;
Li, Jiahe ;
Yang, Herman ;
Milsom, Jeff ;
Lee, Sang ;
Zipfel, Warren ;
Jin, Moonsoo M. ;
Guemues, Zeynep H. ;
Lipkin, Steven M. ;
Shen, Xiling .
CELL STEM CELL, 2013, 12 (05) :602-615
[10]   Synthetic Lethality of PARP Inhibitors in Combination with MYC Blockade Is Independent of BRCA Status in Triple-Negative Breast Cancer [J].
Carey, Jason. P. W. ;
Karakas, Cansu ;
Bui, Tuyen ;
Chen, Xian ;
Vijayaraghavan, Smruthi ;
Zhao, Yang ;
Wang, Jing ;
Mikule, Keith ;
Litton, Jennifer K. ;
Hunt, Kelly K. ;
Keyomarsi, Khandan .
CANCER RESEARCH, 2018, 78 (03) :742-757
12345678910